Obesity management in the pediatric patient
American Journal of Health-System Pharmacy · 2025
DOI: 10.1093/ajhp/zxae236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Health-System Pharmacy, 2025. Verfasst von Kelly L Matson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston, RI, and Department of Pharmacy, UMass Memorial Health - …. Hauptthemen laut MEDLINE: Pediatric Obesity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Purpose
The purpose of this review is to discuss treatment modalities for obesity in children and adolescents, including nonpharmacological, pharmacological, and surgical interventions. Summary The prevalence of pediatric obesity has dramatically risen, with rates of 20.7% and 22.2% among children and adolescents, respectively. Obesity is a complex medical condition with multifactorial risk factors, including diet and exercise, social determinants of health, and environmental and genetic factors. The management approach among children and adolescents with obesity includes nutrition counseling, increased physical activity, and readiness for behavioral change. Pharmacotherapy may be recommended, yet the literature has not elucidated the most appropriate first-line treatment. Metformin and orlistat have been studied and may be considered in pediatric patients with comorbid complications, including type 2 diabetes and nonalcoholic fatty liver disease. Phentermine and topiramate in combination, as well as glucagon-like peptide-1 receptor agonists, have provided modest benefits in weight reduction among youth. Setmelanotide has a unique mechanism of action and may be considered for those with obesity due to genetic disorders. Bariatric surgery should be reserved for adolescents meeting criteria for severe obesity.
Conclusion
Treatment for obesity in children and adolescents includes a comprehensive approach with structured lifestyle programs, mental health support, and mitigation of social determinants of health. Pharmacotherapy may also be considered, yet no medication is recommended over another, giving flexibility for shared decision-making with the patient and family regarding comorbidities and potential drug interactions. Adolescents with severe obesity who meet specified criteria may also be referred for surgical evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston, RI, and Department of Pharmacy, UMass Memorial Health - University Campus, Worcester, MA, USA.
- College of Pharmacy, Natural, and Health Sciences, Manchester University, Fort Wayne, IN, and Department of Pharmacy, Parkview Women's and Children's Hospital, Fort Wayne, IN, USA.
Zitieren
APA
Matson, K. L., & Fenn, N. E. (2025). Obesity management in the pediatric patient. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxae236
Vancouver
Matson KL, Fenn NE. Obesity management in the pediatric patient. American Journal of Health-System Pharmacy. 2025. doi:10.1093/ajhp/zxae236
BibTeX
@article{Matson2025,
author = {Matson, Kelly L and Fenn, Norman E},
title = {Obesity management in the pediatric patient},
journal = {American Journal of Health-System Pharmacy},
year = {2025},
doi = {10.1093/ajhp/zxae236}
}
EUVIMED